Medigen Vaccine Biologics Corp (高端疫苗) has applied to the Australian medicines regulator for provisional approval of its COVID-19 vaccine, the pharmaceutical company said in a filing with the Taipei Exchange yesterday.
The company yesterday delivered the necessary documents to the Australian Therapeutic Goods Administration (TGA), but did not say when the regulator would complete its review, the filing showed.
The TGA in November last year gave the Medigen vaccine a provisional determination, the first step to provisional approval, corporate data showed.
Photo: CNA
The step allows for provisional registration of medicines on the basis of preliminary clinical data.
The TGA said it requires comprehensive non-clinical data on safety, quality and compliance with “good manufacturing practice,” the same as for prescription medicine.
The TGA is one of the world’s most credible regulatory authorities as defined by the WHO, Medigen said in the filing.
The COVID-19 vaccines from AstraZeneca PLC, Moderna Inc, Pfizer Inc and BioNTech SE, Johnson & Johnson, and Novavax Inc have obtained provisional approvals from the TGA.
Medigen’s COVID-19 vaccine has been given emergency use authorization in Taiwan and Paraguay, and the company is waiting for a review to be completed in the Kingdom of Eswatini, while New Zealand, Palau, Indonesia, Belize and Thailand exempt travelers who have received the vaccine without requiring strict quarantine measures, it said.
Medigen reported a net loss of NT$140 million (US$4.76 million) in the first quarter, or losses per share of NT$0.66.
First-quarter revenue advanced to NT$326 million from NT$3 million a year earlier, with gross margin of 64 percent.
The company’s operating expenses grew 27.5 percent annually to NT$361 million last quarter due to higher marketing and research spending, company data showed.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday reported record revenue of NT$416.975 billion (US$13.17 billion) for last month, putting the world’s largest contract chipmaker on track to set a record for quarterly revenue. Last month’s figure surpassed March’s record NT$415.19 billion and represented increases of 1.5 percent from April and 30.1 percent from a year earlier. For the first five months of the year, TSMC generated NT$1.96 trillion in revenue, up 30 percent year-on-year, it said in a statement. TSMC has forecast second-quarter revenue of between US$39 billion and US$40.2 billion, representing sequential growth of about 10 percent and year-on-year growth of about
Infineon Technologies AG is preparing to open its largest single investment, a 5 billion euro (US$5.8 billion) semiconductor factory built with the help of EU subsidies, as the bloc seeks to boost chip production. The power chip fab, which is an extension of the German company’s Dresden campus, is scheduled to open on July 2, Infineon chief operating officer Alexander Gorski said this week at the site. The project is a major recipient of EU Chips Act funds, receiving about 1 billion euros in subsidies. The new plant represents a rare success for the bloc’s flagship semiconductor law, which was drawn up during
PATENT PROBE: US lawmakers called for a ban on imports of chips made by TSMC if they are found to infringe on US patents, with a preliminary ruling expected soon Minister of Economic Affairs Kung Ming-hsin (龔明鑫) yesterday expressed confidence in Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) compliance with patent regulations after reports linked the company to a patent infringement lawsuit in the US. US Representative Ryan Zinke, and US senators Tim Sheehy, Roger Marshall and Bernie Moreno urged the US International Trade Commission in a May 22 letter to ban imports of chips made by TSMC if they are found to infringe on US patents, Axios reported on Wednesday. An administrative law judge is expected to issue a preliminary ruling this month, with the commission potentially making a final decision in
Taiwan remained the sixth-largest net creditor nation in the world last year, despite a fall of more than 10 percent in its net international investment position (NIIP) over the year, the central bank said yesterday. The NIIP is the difference between a country’s external financial assets and its external financial liabilities. Taiwan’s external financial assets hit US$3.27 trillion at the end of last year, up US$275.75 billion or 9.2 percent from a year earlier, the central bank said in its annual NIIP report. The growth largely reflected an increase in holdings of overseas marketable securities by residents in Taiwan, as well as a
RSS